filecrux
$EBS Emergent BioSolutions, maker of anthrax and smallpox vaccines and NARCAN, named only an interim CFO: Treasurer Frank Vargo, 43, treasurer since November 2025, replaces CFO of 8+ years Richard Lindahl, and no permanent pick is named. That's at a ~$368.1M company (at $7.18, 16:00 ET Oct 15, 2026) with $589.7M total debt and $139.7M cash at June 30, 2026 (net debt $450.0M); in Q3, $68M cash retired $75M of unsecured bonds. Offset: Lindahl stays as an advisor until he retires March 31, 2027 and helps file the FY2026 10-K. Vargo takes over Jan 1, 2027.
2
1
